Skip to main content
SpringerLink
Log in

Functional capacity of Mcl-1-specific cytotoxic T-cells

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Andersen MH, Becker JC, thor Straten P . The anti-apoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients. Leukemia 2005; 19: 484–485.

    Article  CAS  Google Scholar 

  2. Andersen MH, Kvistborg P, Becker JC, thor Straten P . Identification of an HLA-A1 restricted CTL epitope from Mcl-1. Leukemia 2005; 19: 1084–1085.

    Article  CAS  Google Scholar 

  3. Mocellin S, Semenzato G, Mandruzzato S, Riccardo RC . Part II: Vaccines for haematological malignant disorders. Lancet Oncol 2004; 5: 727–737.

    Article  CAS  Google Scholar 

  4. Zapata JM, Krajewska M, Krajewski S, Huang RP, Takayama S, Wang HG et al. Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors. Breast Cancer Res Treat 1998; 47: 129–140.

    Article  CAS  Google Scholar 

  5. Tang L, Tron VA, Reed JC, Mah KJ, Krajewska M, Li G et al. Expression of apoptosis regulators in cutaneous malignant melanoma. Clin Cancer Res 1998; 4: 1865–1871.

    CAS  PubMed  Google Scholar 

  6. Shangary S, Johnson DE . Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family. Leukemia 2003; 17: 1470–1481.

    Article  CAS  Google Scholar 

  7. Zhang B, Gojo I, Fenton RG . Myeloid cell factor-1 is a critical survival factor for multiple myeloma. Blood 2002; 99: 1885–1893.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Inge Marie Svane, Herlev University Hospital for collection of blood samples. We thank Professor A. Svejgaard and Ms. Bodil K. Jakobsen, Department of Clinical Immunology, University Hospital, Copenhagen, for HLA-typing of patient blood samples. This study was supported by grants from the Danish Medical Research Council, The Novo Nordisk Foundation, The Danish Cancer Society, The John and Birthe Meyer Foundation, and Danish Cancer Research Foundation.

Author information

Authors and Affiliations

  1. Tumor Immunology Group, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark

    R B Sørensen, P thor Straten & M H Andersen

  2. Department of Hematology, State University Hospital, Copenhagen, Denmark

    O J Nielsen

Authors
  1. R B Sørensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O J Nielsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P thor Straten
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M H Andersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sørensen, R., Nielsen, O., thor Straten, P. et al. Functional capacity of Mcl-1-specific cytotoxic T-cells. Leukemia 20, 1457–1458 (2006). https://doi.org/10.1038/sj.leu.2404261

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404261

  • Springer Nature Limited

This article is cited by

Search

Navigation